Robotic retroperitoneal lymph node dissection for testicular cancer: feasibility and latest outcomes

Robotic-assisted laparoscopic retroperitoneal lymph node dissection (R-RPLND) is gaining acceptance as an alternative to open and laparoscopic RPLND for the treatment of testicular cancer. We discuss the current state of R-RPLND and summarize the latest relevant literature regarding the feasibility...

Full description

Saved in:
Bibliographic Details
Published inCurrent opinion in urology Vol. 29; no. 2; p. 173
Main Authors Mittakanti, Harsha R, Porter, James R
Format Journal Article
LanguageEnglish
Published United States 01.03.2019
Subjects
Feasibility Studies
Humans
Laparoscopy
Lymph Node Excision - methods
Male
Retroperitoneal Space
Robotic Surgical Procedures
Testicular Neoplasms - surgery
Treatment Outcome
Online AccessGet more information

Cover

More Information
Summary:Robotic-assisted laparoscopic retroperitoneal lymph node dissection (R-RPLND) is gaining acceptance as an alternative to open and laparoscopic RPLND for the treatment of testicular cancer. We discuss the current state of R-RPLND and summarize the latest relevant literature regarding the feasibility of this operation. R-RPLND has been utilized effectively for both treatment of high-risk, clinical stage I testicular cancer as well as in the postchemotherapy setting. The feasibility of R-RPLND has been established with complication rates comparable to open RPLND and with decreased postoperative hospital stay and blood loss. As R-RPLND continues to evolve and experience grows in high-volume centers, more information will be gained regarding long-term oncologic outcomes. Ultimately, head-to-head trials comparing R-RPLND to open RPLND will be needed to determine the role of R-RPLND in the treatment of testicular cancer.
ISSN:1473-6586
DOI:10.1097/MOU.0000000000000582